Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, October 24, 2026

Back to today

From X

@aleabitoreddit

Serenity on X

Good question! Just some informal thoughts... there's three "moats" to look at for $SIVE: - Capacity - Qualifications (especially for custom DFB lasers) - Technological 1. For capacity, they're coming online with 100M+ CW DFB lasers Q4 2027 (global supply is roughly ~608M EML/CW lasers currently per Trendforce). Obviously by 2027 global capacity is going to grow a lot, with $AAOI, $AVGO (3x expansion), and others coming online. But if you extrapolate their 2:1 statement, that implies 300m lasers/year long term coming from their own supply + external foundries. This is incredibly valuable during a shortage that was quoted to be 3-5 years, and $LITE stating they already have demand visibility into 2031... And when suppliers have started to qualify many more (eg. 5-7 vendors vs. 2-3 earlier) due to bottlenecks. I'm sure a lot of how they achieve that staggering amount is due to their manufacturing process/yields (which is a moat). 2. For qualifications, if you look at 70mW/100mW pluggable lines with Chinese players, I'd argue this is more generic and moreso reverting back to a capacity argument and manufacturing process to achieve those numbers. Custom DFB arrays that they've been working on with Ayar (they hinted at 2-3 others back in 2023 like Celestial) take years for optical i/o related things and would be a moat if they finish quals. So it's not quite something you can hot swap or design out really easily for $MTSI or another company. But of course cpo scale up and such is mass volume in 2028, and we're still H2 2026. 3. People can always compare raw specs like power output, but it's probably way way more nuanced so easier to just point toward customer statements. With $JBL 1.6T LRO: "I think that there's the potential for a relatively dramatic moat with our LRO part…" from Jabil's EVP, especially related to power consumption. And $SIVE is my guess sole source in this line. Jabil is probably the most important testament to how their lasers perform in mass production scenarios maybe around Q2 next year. Ayar said something similar along the lines of "we couldn't do it without Sivers" for custom implementations.
@aleabitoreddit

Serenity on X

Someone did ask “How is Serenity” this time around! So I’m happy. I’m just personally excited about $LITE selling out into 2029 and implications for optical peers like $AAOI. Not advice, but I personally think markets haven’t fully caught onto the scale of AOI’s ramp in 2027 + current bottleneck severity. It’s one of my largest positions right now for a reason! Also I’m looking forward to touching grass over the weekend. Apparently there was an OCP San Jose event… Maybe I’ll drop by if there’s a Kiss of Life group like at ICML.

Investor Letters

All letters

MYR Group q3’26 Earnings Preview

MYR Group’s Q3 2026 preview cites data-center and power transmission demand, with long-term service agreements supporting margin growth and…

MYRG $4B
Monte Independent Investment Research 5 clicks

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.5B
Latticework by MOI Global 34 clicks

Mosaic, Part Two: The Deep Dive

Mosaic, NYSE: MOS, is the subject of a second audio program for professional investors analyzing fertilizer producers.

MOS $5.5B
Latticework by MOI Global 5 clicks

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $104M
Triple S Special Situations Investing 4 clicks

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

GLOO $269M
Guardian Research 4 clicks
PYPD · long

Polypid LTD

PolyPid, an $80 million Israeli biotech, fell nearly 30% despite solving a clinical problem.

PYPD $106M
Value Investors Club

Why I sold OB pick for 26 SVM

Silvercorp’s falling Ying grades, prolonged GC suspension, El Domo execution risk and Chaarat funding needs weaken its valuation despite…

SVM $2B
The Oak Bloke 27 clicks

Vicor Update, Part Three

Vicor’s $66.6 million in AI power-delivery royalties generated about $50 million of operating profit, eclipsing its module business as…

VICR $8.1B
CV's Substack 28 clicks

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $74M
Calvin Blissett 11 clicks

Monte Investments Market Brief Vol. CXXXII

CoreWeave and neocloud peers face financing pressure, but sold-out GPU capacity and rising H100 and B200 rental rates support continued AI…

MYRG $4B
Monte Independent Investment Research 8 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 62 of 254

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.